Welcome to the Starpharma Investor CentreStarpharma Holdings Limited is an Australian stock exchange listed biotechnology company with products based on its dendrimer technology platform. |
 |
Latest News & Announcements
Starpharma to present DEP® at Radiopharmaceuticals Summit (ASX Announcement)
Dec 6th, 2023
Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it is presenting at the Targeted Radiopharmaceuticals Summit Europe, having been invited to present at the specialist radiotheranostics conference being held in Berlin, Germany, from 5 to 7 December 2023.
Read More
Notice of Annual General Meeting 2023 - Clarification (ASX Announcement)
Nov 15th, 2023
Starpharma refers to its Notice of Annual General Meeting dated 27 October 2023 (Notice).
Read More
Reports & Presentations
Click here for financial reports archive
Starpharma to present DEP® at Radiopharmaceuticals Summit (ASX Announcement)
Dec 6th, 2023
Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it is presenting at the Targeted Radiopharmaceuticals Summit Europe, having been invited to present at the specialist radiotheranostics conference being held in Berlin, Germany, from 5 to 7 December 2023.
Read More
Results of 2023 Annual General Meeting (ASX Announcement)
Nov 30th, 2023
Melbourne, Australia; 29 November 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) announces the details of the resolutions and the proxies and votes received in respect of each resolution at its Annual General Meeting (AGM) held today in accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, as set out in the attached proxy and voting summary. ... View/download... Read More